SPHERE - Study of Perinatal, paediatric and adolescent Health: Epidemiological Research and Evaluation

Equipe constitutive du CERPOP, UMR1295, unité mixte INSERM - Université Toulouse III Paul Sabatier
Valériane LEROY •  chercheure, MD PHD, Santé publique

                 
  
2023
  1. Crichton S, Jesson J, Aké-Assi MH, Belfrage E, Davies MA, Pinto J, Teasdale C, Van Lam N, Vreeman R, Paul M, Williams P, Yotebieng M, Leroy V, Goodall R; Group authorship: Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration; Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration. Global variations in pubertal growth spurts in adolescents living with perinatal HIV. . AIDS. 2023 Aug 1;37(10):1603-1615. doi: 10.1097/QAD.0000000000003602.
  2. Dugdale CM, Ufio O, Alba C, Permar SR, Stranix-Chibanda L, Cunningham CK, Fouda GG, Myer L, Weinstein MC, Leroy V, McFarland EJ, Freedberg KA, Ciaranello AL. Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settings. J Int AIDS Soc. 2023 Jan;26(1):e26052. doi: 10.1002/jia2.26052.
  3. Guindo A, Cisse Z, Keita I, Desmonde S, Sarro YDS, Touré BA, Baraika MA, Tessougué O, Guindo P, Coulibaly M, Traore O, Sylla N, Diassana M, Saye A, Picot V, Lauressergues E, Leroy V. Potential for a large-scale newborn screening strategy for sickle cell disease in Mali: A comparative diagnostic performance study of two rapid diagnostic tests (SickleScan® and HemotypeSC®) on cord blood. Br J Haematol. 2023 Sep 20. doi: 10.1111/bjh.19108. Epub ahead of print.
  4. Humphrey J, Nagel E, Carlucci JG, Edmonds A, Kinikar A, Anderson K, Leroy V, Machado D, Yin DE, Tulio Luque M, Amorissani-Folquet M, Mbewe S, Suwanlerk T, Munyaneza A, Patel RC, Musick B, Abuogi L, Wools-Kaloustian K. Integration of HIV care into maternal and child health services in the global IeDEA consortium. Front Glob Womens Health. 2023 Apr 17;4:1066297. doi: 10.3389/fgwh.2023.1066297.
  5. Saint-Lary L, Benevent J, Damase-Michel C, Vayssière C, Leroy V, Sommet A. Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2023 Jan 30;23(1):80. doi: 10.1186/s12884-023-05347-5.
  6. Townsend CL, O'Rourke J, Milanzi E, Collins IJ, Judd A, Castro H, Vicari M, Jesson J, Leroy V, Renaud F, Penazzato M. Effectiveness and safety of dolutegravir and raltegravir for treating children and adolescents living with HIV: a systematic review. J Int AIDS Soc. 2022 Nov;25(11):e25970. doi: 10.1002/jia2.25970.
  7. Turkova A, White E, Kekitiinwa AR, Mumbiro V, Kaudha E, Liberty A, Ahimbisibwe GM, Moloantoa T, Srirompotong U, Mosia NR, Puthanakit T, Kobbe R, Fortuny C, Kataike H, Bbuye D, Na-Rajsima S, Coelho A, Lugemwa A, Bwakura-Dangarembizi MF, Klein N, Mujuru HA, Kityo C, Cotton MF, Ferrand RA, Giaquinto C, Rojo P, Violari A, Gibb DM, Ford D; ODYSSEY trial team (Leroy V collaborator). Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial. Lancet Child Adolesc Health. 2023 Oct;7(10):718-727. doi: 10.1016/S2352-4642(23)00164-5.
  8. Vreeman RC, Yiannoutsos CT, Yusoff NKN, Wester CW, Edmonds A, Ofner S, Davies MA, Leroy V, Lumbiganon P, de Menezes Succi RC, Twizere C, Brown S, Bolton-Moore C, Takassi OE, Scanlon M, Martin R, Wools-Kaloustian K; IeDEA. Global HIV prevention, care and treatment services for children: a cross-sectional survey from the International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium. BMJ Open. 2023 Mar 13;13(3):e069399. doi: 10.1136/bmjopen-2022-069399.
  9. A quantitative assessment of the effect on emergency room visits and hospitalizations of an innovative departmental system for dealing with crisis situations of adolescents in Haute-Garonne, France. Article in press
2022
  1. Adamou R, de Freitas Girardi J, Aka Dago-Akribi H, Dassi Tchoupa Revegue MH, Cacou MC, Moh C, Bouah B, Agbo P, Msellati P, Raynaud JP, Leroy V, Sturm G. Étude qualitative sur le vécu de l’annonce du statut VIH aux adolescents en Côte d’Ivoire. Sante Publique. 2022;33(5):753-762. doi: 10.3917/spub.215.0753.
  2. Amuge P, Lugemwa A, Wynne B, Mujuru HA, Violari A, Kityo CM, Archary M, Variava E, White E, Turner RM, Shakeshaft C, Ali S, Nathoo KJ, Atwine L, Liberty A, Bbuye D, Kaudha E, Mngqibisa R, Mosala M, Mumbiro V, Nanduudu A, Ankunda R, Maseko L, Kekitiinwa AR, Giaquinto C, Rojo P, Gibb DM, Turkova A, Ford D; ODYSSEY Trial Team (Leroy V collaborator). Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial. Lancet HIV. 2022 Sep;9(9):e638-e648. doi: 10.1016/S2352-3018(22)00163-1.
  3. Brazier E, Ajeh R, Maruri F, Musick B, Freeman A, Wester CW, Lee MP, Shamu T, Crabtree Ramírez B, d'Almeida M, Wools-Kaloustian K, Kumarasamy N, Althoff KN, Twizere C, Grinsztejn B, Tanser F, Messou E, Byakwaga H, Duda SN, Nash D; International epidemiology Databases to Evaluate AIDS (Desmonde S, Dahourou D, Leroy V collaborators). Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium. J Int AIDS Soc. 2022 Dec;25(12):e26036. doi: 10.1002/jia2.26036.
  4. Breton G, Diallo OH, Cissé M, Diallo OH, Diallo NA, Soumaoro SA, Camara Y, Montoyo A, Rouzioux C, Koita Y, Peytavin G, Tubiana R, Frange P; ANRS 12344-DIAVINA study group (Leroy V collaborator). HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study. J Antimicrob Chemother. 2022 Oct 28;77(11):3093-3101. doi: 10.1093/jac/dkac287.
  5. Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, Jesson J, Crichton S, Quartagno M, Yotebieng M, Abrams EJ, Chokephaibulkit K, Le Coeur S, Aké-Assi MH, Patel K, Pinto J, Paul M, Vreeman R, Davies MA, Ben-Farhat J, Van Dyke R, Judd A, Mofenson L, Vicari M, Seage G 3rd, Bekker LG, Essajee S, Gibb D, Penazzato M, Collins IJ, Wools-Kaloustian K, Slogrove A, Powis K, Williams P, Matshaba M, Thahane L, Nyasulu P, Lukhele B, Mwita L, Kekitiinwa-Rukyalekere A, Wanless S, Goetghebuer T, Thorne C, Warszawski J, Galli L, van Rossum AMC, Giaquinto C, Marczynska M, Marques L, Prata F, Ene L, Okhonskaya L, Navarro M, Frick A, Naver L, Kahlert C, Volokha A, Chappell E, Pape JW, Rouzier V, Marcelin A, Succi R, Sohn AH, Kariminia A, Edmonds A, Lelo P, Lyamuya R, Ogalo EA, Odhiambo FA, Haas AD, Bolton C, Muhairwe J, Tweya H, Sylla M, D'Almeida M, Renner L, Abzug MJ, Oleske J, Purswani M, Teasdale C, Nuwagaba-Biribonwoha H, Goodall R, Leroy V. Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis. J Int AIDS Soc. 2022 Mar;25(3):e25871. doi: 10.1002/jia2.25871.
  6. Edmonds A, Brazier E, Musick BS, Yotebieng M, Humphrey J, Abuogi LL, Adedimeji A, Keiser O, Msukwa M, Carlucci JG, Maia M, Pinto JA, Leroy V, Davies MA, Wools-Kaloustian KK; IeDEA. Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study. PLoS Med. 2022 Sep 15;19(9):e1004089. doi: 10.1371/journal.pmed.1004089.
  7. Jesson J, Saint-Lary L, Revegue MHDT, O'Rourke J, Townsend CL, Renaud F, Penazzato M, Leroy V. Safety and efficacy of abacavir for treating infants, children, and adolescents living with HIV: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2022 Oct;6(10):692-704. . doi: 10.1016/S2352-4642(22)00213-9.
  8. Renaud F, Mofenson LM, Bakker C, Dolk H, Leroy V, Namiba A, Sahin L, Shapiro R, Slogrove A, Thorne C, Vicari M, Low-Beer D, Doherty M. Surveillance of ARV safety in pregnancy and breastfeeding: towards a new framework. J Int AIDS Soc. 2022 Jul;25 Suppl 2(Suppl 2):e25922. doi: 10.1002/jia2.25922.
  9. Rojo P, Moraleda C, Tagarro A, Domínguez-Rodríguez S, Castillo LM, Tato LMP, López AS, Manukyan L, Marcy O, Leroy V, Nardone A, Burger D, Bassat Q, Bates M, Moh R, Iroh Tam PY, Mvalo T, Magallhaes J, Buck WC, Sacarlal J, Musiime V, Chabala C, Mujuru HA. Empirical treatment against cytomegalovirus and tuberculosis in HIV-infected infants with severe pneumonia: study protocol for a multicenter, open-label randomized controlled clinical trial. Trials. 2022 Jun 27;23(1):531. doi: 10.1186/s13063-022-06203-1.
  10. Saint-Lary L, Dassi Tchoupa Revegue MH, Jesson J, Renaud F, Penazzato M, Townsend CL, O'Rourke J, Leroy V; WHO HIV Hepatitis and STIs (HHS) Department. Effectiveness and Safety of Atazanavir Use for the Treatment of Children and Adolescents Living With HIV: A Systematic Review. Front Pediatr. 2022 May 23;10:913105. doi: 10.3389/fped.2022.913105.
  11. Saint-Lary L, Diallo A, de Monteynard LA, Paul C, Marchand L, Tubiana R, Warszawski J, Mandelbrot L, Rekacewicz C, Petrov-Sanchez V, Faye A, Sibiude J, Dabis F, Sommet A, Leroy V. In utero exposure to antiretroviral drugs and pregnancy outcomes: Analysis of the French ANRS pharmacovigilance database. Br J Clin Pharmacol. 2022 Mar;88(3):942-964. doi: 10.1111/bcp.15075.
  12. Townsend CL, O'Rourke J, Milanzi E, Collins IJ, Judd A, Castro H, Vicari M, Jesson J, Leroy V, Renaud F, Penazzato M. Effectiveness and safety of dolutegravir and raltegravir for treating children and adolescents living with HIV: a systematic review. J Int AIDS Soc. 2022 Nov;25(11):e25970. doi: 10.1002/jia2.25970.
  13. Turkova A, Waalewijn H, Chan MK, Bollen PDJ, Bwakura-Dangarembizi MF, Kekitiinwa AR, Cotton MF, Lugemwa A, Variava E, Ahimbisibwe GM, Srirompotong U, Mumbiro V, Amuge P, Zuidewind P, Ali S, Kityo CM, Archary M, Ferrand RA, Violari A, Gibb DM, Burger DM, Ford D, Colbers A; ODYSSEY Trial Team (Leroy V collaborator). Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial. Lancet HIV. 2022 Sep;9(9):e627-e637. doi: 10.1016/S2352-3018(22)00160-6.
2021
  1. Dassi Tchoupa Revegue MH, Takassi UE, Tanoh Eboua F, Desmonde S, Amoussou-Bouah UB, Bakai TA, Jesson J, Dahourou DL, Malateste K, Aka-Dago-Akribi H, Raynaud JP, Arrivé E, Leroy V. 24-Month Clinical, Immuno-Virological Outcomes, and HIV Status Disclosure in Adolescents Living With Perinatally-Acquired HIV in the IeDEA-COHADO Cohort in Togo and Côte d'Ivoire, 2015-2017. Front Pediatr. 2021 Jun 30;9:582883. doi: 10.3389/fped.2021.582883.
  2. Jesson J, Kouakou EK, Kumaran K, Adonis L, Wrottesley SV, Leroy V, Fall C; TALENT collaboration. A scoping review of literature describing the nutritional status and diets of adolescents in Côte d'Ivoire. Public Health Nutr. 2021 Nov;24(16):5261-5276. doi: 10.1017/S1368980020002621.
  3. Desmonde S, Ciaranello AL, Malateste K, Musick B, Patten G, Vu AT, Edmonds A, Neilan AM, Duda SN, Wools-Kaloustian K, Davies MA, Leroy V; IeDEA Consortium. Age-specific mortality rate ratios in adolescents and youth aged 10-24 years living with perinatally versus nonperinatally acquired HIV. AIDS. 2021 Mar 15;35(4):625-632. doi: 10.1097/QAD.0000000000002765.
  4. Jesson J, Ephoevi-Ga A, Aké-Assi MH, Koumakpai S, N'Gbeche S, Dainguy E, Malateste K, Carrié H, D'Almeida M, Eboua FT, Takassi E, Amorissani-Folquet M, Leroy V; IeDEA West African Pediatric Collaboration. Assessment of dietary diversity and nutritional support for children living with HIV in the IeDEA pediatric West African cohort: a non-comparative, feasibility study. BMC Nutr. 2021 Dec 14;7(1):83. doi: 10.1186/s40795-021-00486-4.
  5. Jesson J, Kouakou EK, Hardy-Johnson P, Ngoran-Theckly P, Kehoe SH, Adonis L, Fall C, Leroy V, Barker M, Weller S; TALENT Collaboration. Adolescent nutrition and physical activity in low-income suburbs of Abidjan, Côte d'lvoire: the gap between knowledge, aspirations and possibilities. Public Health Nutr. 2021 Nov;24(16):5227-5237. doi: 10.1017/S1368980020001809.
  6. Jesson J, Kouakou EK, Kumaran K, Adonis L, Wrottesley SV, Leroy V, Fall C, collaboration T. A scoping review of literature describing the nutritional status and diets of adolescents in Cote d'Ivoire. Public Health Nutr. 2021;24(16):5261-76. doi: 10.1017/S1368980020002621.
  7. Moore CL, Turkova A, Mujuru H, Kekitiinwa A, Lugemwa A, Kityo CM, Barlow-Mosha LN, Cressey TR, Violari A, Variava E, Cotton MF, Archary M, Compagnucci A, Puthanakit T, Behuhuma O, Saϊdi Y, Hakim J, Amuge P, Atwine L, Musiime V, Burger DM, Shakeshaft C, Giaquinto C, Rojo P, Gibb DM, Ford D; ODYSSEY Trial Team (Leroy V collaborator). ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing. BMC Infect Dis. 2021 Jan 4;21(1):5. doi: 10.1186/s12879-020-05672-6.
  8. Pressiat C, Dainguy E, Treluyer J, Yonaba C, Urien S, Eboua F, Foissac F, Dahourou DL, Bouazza N, Malateste K, Desmonde S, Pruvost A, Leroy V, Hirt D, for the MONOD ANRS Study Group. Comparison of three galenic forms of lamivudine in young West African children living with HIV. Antiviral Therapy. 2021. 26(6-8):135965352110582. doi : 10.1177/13596535211058267
  9. Pressiat C, Toni TD, Treluyer JM, Yonaba C, Dahourou DL, Malateste K, Seguin-Devaux C, Leroy V, Hirt D; MONOD ANRS Study Group. High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy. AIDS. 2021 Nov 15;35(14):2409-2410. doi: 10.1097/QAD.0000000000003043.
  10. Tchounga B, Horo A, Boni S, Tanon A, Folquet MA, Garrigue I, Leroy V, Dabis F, Ekouevi D, Jaquet A. Human papilloma viruses infection among adolescent females perinatally infected with HIV in Côte d'Ivoire. Sex Transm Infect. 2021 May;97(3):238-243. doi: 10.1136/sextrans-2019-054420.
  11. Turkova A, White E, Mujuru HA, Kekitiinwa AR, Kityo CM, Violari A, Lugemwa A, Cressey TR, Musoke P, Variava E, Cotton MF, Archary M, Puthanakit T, Behuhuma O, Kobbe R, Welch SB, Bwakura-Dangarembizi M, Amuge P, Kaudha E, Barlow-Mosha L, Makumbi S, Ramsagar N, Ngampiyaskul C, Musoro G, Atwine L, Liberty A, Musiime V, Bbuye D, Ahimbisibwe GM, Chalermpantmetagul S, Ali S, Sarfati T, Wynne B, Shakeshaft C, Colbers A, Klein N, Bernays S, Saïdi Y, Coelho A, Grossele T, Compagnucci A, Giaquinto C, Rojo P, Ford D, Gibb DM; ODYSSEY Trial Team (Leroy V collaborator). Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children. N Engl J Med. 2021 Dec 30;385(27):2531-2543. doi: 10.1056/NEJMoa2108793.
2020
  1. Barker ME, Hardy-Johnson P, Weller S, Haileamalak A, Jarju L, Jesson J, Krishnaveni GV, Kumaran K, Leroy V, Moore SE, Norris SA, Patil S, Sahariah SA, Ward K, Yajnik CS, Fall C; TALENT collaboration. How do we improve adolescent diet and physical activity in India and sub-Saharan Africa? Findings from the Transforming Adolescent Lives through Nutrition (TALENT) consortium. Public Health Nutr. 2020 Oct 28:1-9. doi: 10.1017/S1368980020002244.
  2. Bernard C, Font H, Diallo Z, Ahonon R, Tine JM, N'guessan Abouo F, Tanon A, Messou E, Seydi M, Dabis F, de Rekeneire N; IeDEA West Africa Cohort Collaboration (Desmonde S, Leroy V collaborators). Prevalence and factors associated with severe depressive symptoms in older west African people living with HIV. BMC Psychiatry. 2020 Sep 10;20(1):442. doi: 10.1186/s12888-020-02837-0.
  3. Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration (Desmonde S, Leroy V collaborator). Outcomes of second-line antiretroviral therapy among children living with HIV: a global cohort analysis. J Int AIDS Soc. 2020;23(4):e25477. doi: 10.1002/jia25477.
  4. Desmonde S, Ciaranello AL, Malateste K, Musick B, Patten G, Vu AT, Edmonds A, Neilan AM, Duda SN, Wools-Kaloustian K, Davies MA, Leroy V; IeDEA consortium. Age-specific mortality rate ratios in adolescents and youth aged 10-24 years living with perinatally versus non-perinatally-acquired HIV. AIDS. 2020 Nov 26. doi: 10.1097/QAD.0000000000002765.
  5. Desmonde S, Neilan AM, Musick B, Patten G, Chokephaibulkit K, Edmonds A, Duda SN, Malateste K, Wools-Kaloustian K, Ciaranello AL, Davies MA, Leroy V; IeDEA. Time-varying age- and CD4-stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA Global Cohort Consortium. J Int AIDS Soc. 2020 Oct;23(10):e25617. doi: 10.1002/jia2.25617.
  6. Ekat MH, Yotebieng M, Leroy V, Mpody C, Diafouka M, Loubaki G, Nsondé DM-, Ossibi Ibara BR, Bernard C, Sabin C, Becquet R. Association between depressive symptoms and adherence among adolescents living with HIV in the Republic of Congo: A cross sectional study. Medicine (Baltimore). 2020 Aug 28;99(35):e21606. doi: 10.1097/MD.0000000000021606.
  7. Jesson J, Desmonde S, Yiannoutsos CT, Patten G, Malateste K, Duda SN, Kumarasamy N, Yotebieng M, Davies MA, Musick B, Leroy V, Ciaranello A; IeDEA. Weight-for-age distributions among children with HIV on antiretroviral therapy in the International epidemiology Databases to Evaluate AIDS (IeDEA) multiregional consortium. BMC Res Notes. 2020 May 24;13(1):249. doi: 10.1186/s13104-020-05081-7.
  8. Jesson J, Kouakou EK, Kumaran K, Adonis L, Wrottesley SV, Leroy V, Fall C; TALENT collaboration. A scoping review of literature describing the nutritional status and diets of adolescents in Côte d'Ivoire. Public Health Nutr. 2020 Sep 4:1-16. doi:  10.1017/S1368980020002621.
                  2019
  1. Boettiger DC, Law MG, Sohn AH, Davies MA, Wools-Kaloustian K, Leroy V, Yotebieng M, Vinikoor M, Vreeman R, Amorissani-Folquet M, Edmonds A, Fatti G, Batte J, Renner L, Adedimeji A, Kariminia A; International Epidemiology Databases to Evaluate AIDS. Temporal Trends in Co-trimoxazole Use Among Children on Antiretroviral Therapy and the Impact of Co-trimoxazole on Mortality Rates in Children Without Severe Immunodeficiency. J Pediatric Infect Dis Soc. 2019 Nov 6;8(5):450-460. doi: 10.1093/jpids/piy087.
  2. Dahourou DL, Masson D, Aka-Dago-Akribi H, Gauthier-Lafaye C, Cacou C, Raynaud JP, Moh C, Bouah B, Sturm G, Oga M, Msellati P, Leroy V; Le Groupe Atelier Annonce Adolescents Afrique. Annonce à l’enfant et à l’adolescent de son statut VIH en Afrique francophone centrale et de l’Ouest [HIV Disclosure to the Child/Adolescent in Central and West Francophone Africa]. Bull Soc Pathol Exot. 2019;112(1):14-21. French. doi: 10.3166/bspe-2019-0063.
  3. Desmonde S, Frank SC, Coovadia A, Dahourou DL, Hou T, Abrams EJ, Amorissani-Folquet M, Walensky RP, Strehlau R, Penazzato M, Freedberg KA, Kuhn L, Leroy V, Ciaranello AL. Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency Virus. Open Forum Infect Dis. 2019 Jun 11;6(7):ofz276. doi: 10.1093/ofid/ofz276.
  4. Ekali GL, Jesson J, Enok PB, Leroy V. Effect of in utero exposure to HIV and antiretroviral drugs on growth in HIV-exposed uninfected children: a systematic review and meta-analysis protocol. BMJ Open. 2019 Jun 21;9(6):e023937. doi: 10.1136/bmjopen-2018-023937.
  5. Jesson J, Ephoevi-Ga A, Desmonde S, Ake-Assi MH, D'Almeida M, Sy HS, Malateste K, Amorissani-Folquet M, Dicko F, Kouadio K, Renner L, Leroy V; IeDEA West African Pediatric Collaboration. Growth in the first 5 years after antiretroviral therapy initiation among HIV-infected children in the IeDEA West African Pediatric Cohort. Trop Med Int Health. 2019 Jun;24(6):775-785. doi: 10.1111/tmi.13237.
  6. Jesson J, Schomaker M, Malasteste K, Wati DK, Kariminia A, Sylla M, Kouadio K, Sawry S, Mubiana-Mbewe M, Ayaya S, Vreeman R, McGowan CC, Yotebieng M, Leroy V, Davies MA; IeDEA global cohort consortium. Stunting and growth velocity of adolescents with perinatally acquired HIV: differential evolution for males and females. A multiregional analysis from the IeDEA global paediatric collaboration. J Int AIDS Soc. 2019 Nov;22(11):e25412. doi: 10.1002/jia2.25412.
  7. Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration (Desmonde S, Leroy V, writing group members). Incidence of switching to second-line antiretroviral therapy and associated factors in children with HIV: an international cohort collaboration. Lancet HIV. 2019 Feb;6(2):e105-e115. doi:  10.1016/S2352-3018(18)30319-9.  Erratum in: Lancet HIV. 2020 Jan 28.
  8. Schomaker M, Luque-Fernandez MA, Leroy V, Davies MA. Using longitudinal targeted maximum likelihood estimation in complex settings with dynamic interventions. Stat Med. 2019 Oct 30;38(24):4888-4911. doi: 10.1002/sim.8340.
  9. Yotebieng M, Brazier E, Addison D, Kimmel AD, Cornell M, Keiser O, Parcesepe AM, Onovo A, Lancaster KE, Castelnuovo B, Murnane PM, Cohen CR, Vreeman RC, Davies MA, Duda SN, Yiannoutsos CT, Bono RS, Agler R, Bernard C, Syvertsen JL, Sinayobye JD, Wikramanayake R, Sohn AH, von Groote PM, Wandeler G, Leroy V, Williams CF, Wools-Kaloustian K, Nash D; IeDEA Treat All in sub-Saharan Africa Consensus Statement Working Group. Research priorities to inform "Treat All" policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA). J Int AIDS Soc. 2019 Jan;22(1):e25218. doi: 10.1002/jia2.25218.
  10. Zürcher K, Ballif M, Kiertiburanakul S, Chenal H, Yotebieng M, Grinsztejn B, Michael D, Sterling TR, Ngonyani KM, Mandalakas AM, Egger M, Pettit AC, Fenner L; International Epidemiology Databases to Evaluate AIDS (IeDEA) consortium (Desmonde S, Leroy V collaborators). Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low- and middle-income countries: a multicohort study. J Int AIDS Soc. 2019 Sep;22(9):e25392. doi: 10.1002/jia2.25392.